Journals - All Articles

PHSS News | Open Access | Published 18th December 2025 PHSS News Dear Members   This year seems to have flown by; we are now approaching the close of 2025.   We have hosted six fantastic events across the year, bringing together the membership, valuable partners and industry from the 2-day Aseptic Workshop in March, through to the most recent Scientific Insights webinar in November. We are focused on providing many ways to engage and share knowledge.   In addition to the core

Medicines are being developed for diseases that were previously untreatable, and new technologies such as cell and gene therapies, gene editing (ATMPs), Antibody Drug Conjugates (ADCs), and Lipid Nano Particles (LNPs) are providing new ways to target these diseases.

Review of Developments in GMP and the Regulation of Medicines December 2025  EJPPS Volume 30.4C INTRODUCTION During the last 4 weeks there have been a number of developments in the regulation of the pharmaceutical industry. This month reported issues have come from the UK, EU, USA and Swiss regulatory authorities. The topics covered in this edition of the “Update” include: UK Medicines and Healthcare products Regulatory Agency (MHRA) ·       Three convicted in major MHRA inve

Review of Developments in GMP and the Regulation of Medicines November 2025  EJPPS Volume 30.4B  INTRODUCTION During the last 4 weeks there have been a number of developments in the regulation of the pharmaceutical industry. This month reported issues have come from the UK, EU, Australia and PIC/S regulatory authorities. The topics covered in this edition of the “Update” include: UK Medicines and Healthcare products Regulatory Agency (MHRA) ·       Regulation in an age of per

Review of Developments in GMP and the Regulation of Medicines Oct 2025 EJPPS Vol 30.4A During the last 4 weeks there have been a number of developments in the regulation of the pharmaceutical industry. This month reported issues have come from the UK, EU, Australian Swiss and USA regulatory authorities. The topics covered in this edition of the “Update” include: UK Medicines and Healthcare products Regulatory Agency (MHRA) ·       Medicines that you cannot export from the UK

Technical Review Article | Open Access | Published 18th December 2025 Microemulgel - A promising novel formulation for topical drug  delivery Gupta Ashish¹, Darwhekar Gajanan¹, Jain Sachin Kumar² | EJPPS | 304 (2025)   https://doi.org/ 10.37521/ejpps30406 Back to Journals  |   Article  |Abstract |  References |  Authors Abstract   Microemulgel is a new and promising drug delivery system employed in the pharmaceutical industry. It is a stable dispersion consisting of an oi

Polysorbates (PS), particularly polysorbate 20 (PS20) and polysorbate 80 (PS80), are widely utilized as non-ionic surfactants in biopharmaceutical formulations. Their primary role is to stabilize therapeutic proteins against interfacial stresses encountered during manufacturing, handling, and storage. Despite their widespread use, PS are complex and heterogeneous mixtures prone to degradation. The two primary degradation pathways are hydrolysis and oxidation. Hydrolytic degra

Technical Review Article | Open Access | Published 18th December 2025 Analytical Method Development for related substances (Organic impurities) in Pharmaceuticals: A Comprehensive review of Methodologies and Regulatory Compliance   Sumeet Dwivedi¹*, Rajesh Kumar Chawla², Naresh Ambekar². | EJPPS | 304 (2025) https://doi.org/10.37521/ejpps30407 Back to Journals  |   Article  |Abstract |  References |  Authors Abstract   The terms "related substances" and "organic impurities"

Peer Review Article | Open Access | Published 18th December 2025 Finding an accurate equation to estimate the osmolarity of parenteral nutrition for preterm baby Suci Hanifah⁠ | EJPPS | 304 (2025) |   https://doi.org/10.37521/ejpps30405 Back to Journals  | Abstract  |  Conclusion  |  References  |  Authors  Abstract Background: Determining the osmolarity of parenteral nutrition (PN) preparations is essential to guide the administration route—whether via peripheral or cent

Peer Review Article | Open Access | Published 18th December 2025 Feasibility assessment of recombinant reagents for the application of endotoxin testing of pharmaceutical waters. P. Cliffe¹ K. Capper*² | EJPPS | 304 (2025) | https://doi.org/10.37521/ejpps30402 Back to Journals  | Abstract |  Conclusion  |  References  |  Appendixes  |  Authors    Abstract  The traditional Limulus amoebocyte lysate (LAL) assay has served as the standard method for detecting bacterial endotoxi